omniture
RESTORE VISION INC.

Latest News

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

* The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. * RV-001 starting do...

2025-02-13 15:00 1726